Frontiers in Genetics (Feb 2024)
Corrigendum: Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease
- Irene Simonetta,
- Renata Riolo,
- Federica Todaro,
- Vincenzo Donadio,
- Alex Incensi,
- Salvatore Miceli,
- Paolo Colomba,
- Giovanni Duro,
- Antonino Tuttolomondo
Affiliations
- Irene Simonetta
- Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promotion, Maternal and Child Health, Internal Medicine and Specialty Excellence “G. D’Alessandro” (PROMISE), University of Palermo, Palermo, Italy
- Renata Riolo
- Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promotion, Maternal and Child Health, Internal Medicine and Specialty Excellence “G. D’Alessandro” (PROMISE), University of Palermo, Palermo, Italy
- Federica Todaro
- Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promotion, Maternal and Child Health, Internal Medicine and Specialty Excellence “G. D’Alessandro” (PROMISE), University of Palermo, Palermo, Italy
- Vincenzo Donadio
- Neuromuscular and Neuroimmunology Unit, Bellaria Hospital, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
- Alex Incensi
- Neuromuscular and Neuroimmunology Unit, Bellaria Hospital, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
- Salvatore Miceli
- Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promotion, Maternal and Child Health, Internal Medicine and Specialty Excellence “G. D’Alessandro” (PROMISE), University of Palermo, Palermo, Italy
- Paolo Colomba
- Institute for Biomedical Research and Innovation (IRIB-CNR), National Research Council of Italy, Palermo, Italy
- Giovanni Duro
- Institute for Biomedical Research and Innovation (IRIB-CNR), National Research Council of Italy, Palermo, Italy
- Antonino Tuttolomondo
- Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promotion, Maternal and Child Health, Internal Medicine and Specialty Excellence “G. D’Alessandro” (PROMISE), University of Palermo, Palermo, Italy
- DOI
- https://doi.org/10.3389/fgene.2024.1368953
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords